Covaxin Bharat Biotech | Covaxin Price | Covaxin Details

Covaxin Bharat Biotech | Covaxin Price | Covaxin Details 

Covaxin Bharat Biotech | Covaxin Price | Covaxin Details,  ''Covaxin''  a first indigeneously developed ''COVID - 19'' vaccine is allowed by Central Drug Standard Control Organisation for human trials. Bharat Biotech India (BBIL) will conduct human clinical trial in July.

Covaxin is developed by Bharat Biotech India (BBIL) against the Noval Coronavirus ''COVID-19''. In India 18,500+ cases are registered everyday. In India 2,15,125 are active cases while 3,34,821 already recovered.

The Bharat Biotech India will conduct COVAXIN on human trial in 2 phases Phase I and Phase II. In Phase I they will try it on small group of individual just to see wheather there are any side effect of it helps to improve immunity.

In Phase II, they will try it on hundreads of people, they will try on humans according to their are, gender etc.

Bharat Biotech India will start the COVAXIN test in July but its unsure - BBIL